Subxiphoid access to normal pericardium with micropuncture set: technical feasibility study in pigs.

This study was performed with approval from the ethics committee for animal research of the local government. The purpose of the study was to evaluate the technical feasibility of a technique for subxiphoid access to the normal pericardial space with a micropuncture set in 10 large white pigs. With fluoroscopic guidance, a fine needle was inserted through a subxiphoid approach into the anterior mediastinal space to puncture the pericardium, and a micropuncture set was placed in the pericardial space successfully in all animals without complications. Necropsy at 24 hours did not reveal hemomediastinum, hemopericardium, or laceration of the pericardium. Results of the experiments in animals indicated that the technique was feasible and safe.

[1]  A. d'Avila,et al.  A New Technique to Perform Epicardial Mapping in the Electrophysiology Laboratory , 1996, Journal of cardiovascular electrophysiology.

[2]  D. Spodick,et al.  Pericardial access using the PerDUCER and flexible percutaneous pericardioscopy. , 2001, The American journal of cardiology.

[3]  A. d'Avila,et al.  Endocardial and Epicardial Ablation Guided by Nonsurgical Transthoracic Epicardial Mapping to Treat Recurrent Ventricular Tachycardia , 1998, Journal of cardiovascular electrophysiology.

[4]  W. Quist,et al.  Preclinical safety testing of percutaneous transatrial access to the normal pericardial space for local cardiac drug delivery and diagnostic sampling , 2000, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[5]  M. Macris,et al.  Minimally invasive access of the normal pericardium: Initial clinical experience with a novel device , 1999, Clinical cardiology.

[6]  D. Spodick.  Intrapericardial therapeutics and diagnostics. , 2000, The American journal of cardiology.

[7]  R. Verrier,et al.  Transatrial access to the normal pericardial space: a novel approach for diagnostic sampling, pericardiocentesis, and therapeutic interventions. , 1998, Circulation.

[8]  Y. Uchida,et al.  Angiogenic therapy of acute myocardial infarction by intrapericardial injection of basic fibroblast growth factor and heparin sulfate: an experimental study. , 1995, American heart journal.

[9]  B. Lorell,et al.  Safety of subxyphoid pericardial access using a blunt-tip needle. , 2002, The American journal of cardiology.

[10]  A. Jacobs,et al.  Intrapericardial basic fibroblast growth factor induces myocardial angiogenesis in a rabbit model of chronic ischemia. , 1995, American heart journal.

[11]  P. Seferovic,et al.  Initial clinical experience with perducer® device: Promising new tool in the diagnosis and treatment of pericardial disease , 1999, Clinical cardiology.

[12]  L. Fei,et al.  Intrapericardial delivery of L-arginine reduces the increased severity of ventricular arrhythmias during sympathetic stimulation in dogs with acute coronary occlusion: nitric oxide modulates sympathetic effects on ventricular electrophysiological properties. , 1997, Circulation.

[13]  M. Simons,et al.  Subxyphoid access of the normal pericardium: A novel drug delivery technique , 1999, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[14]  D. Zipes,et al.  Efficient in vivo catheter‐based pericardial gene transfer mediated by adenoviral vectors , 1999, Clinical cardiology.

[15]  R. Kloner,et al.  Hypothermic, closed circuit pericardioperfusion: a potential cardioprotective technique in acute regional ischemia. , 1998, Journal of the American College of Cardiology.